Sanofi image

Sanofi companions with Brazil to boost up Zika vaccine work

Sanofi companions with Brazil to boost up Zika vaccine work

Sanofi has struck a collaboration address a main Brazilian studies institute to speed development of a Zika vaccine, consolidating the French drug maker’s leading position inside the race to defeat the mosquito-borne virus.

Sanofi image
A logo is seen in front of the entrance at the headquarters French drug maker Sanofi in Paris October 30, 2014.

The deal with the Fiocruz public health center follows a tie-up in July among Sanofi and a U.S. navy research institute, which gave the drug maker access to one of the furthest superior vaccines in development. [nL8N19S0AZ]

Sanofi stated on Thursday that all three studies organizations would now paintings together to “growth the chance of correctly growing and licensing a safe and effective Zika vaccine as quickly as possible”.

The French organization has taken pole function amongst principal drug makers in Zika vaccine studies, reflecting its know-how in growing photographs against other so-referred to as flavi viruses, inclusive of yellow fever, dengue and japanese encephalitis.

In February, the world health company declared a global public fitness emergency because of Zika’s obvious link to microcephaly, a start defect marked by small heads and serious developmental troubles. That has galvanized efforts to hurry up vaccine development.

Leave a Reply

Your email address will not be published. Required fields are marked *